FR09C0037I1 - - Google Patents
Info
- Publication number
- FR09C0037I1 FR09C0037I1 FR09C0037C FR09C0037I1 FR 09C0037 I1 FR09C0037 I1 FR 09C0037I1 FR 09C0037 C FR09C0037 C FR 09C0037C FR 09C0037 I1 FR09C0037 I1 FR 09C0037I1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR19970042001 | 1997-08-28 | ||
| KR19970042002 | 1997-08-28 | ||
| PCT/KR1998/000259 WO1999011762A1 (en) | 1997-08-28 | 1998-08-25 | An attenuated japanese encephalitis virus adapted to vero cell and a japanese encephalitis vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR09C0037I1 true FR09C0037I1 (enrdf_load_html_response) | 2009-09-25 |
| FR09C0037I2 FR09C0037I2 (fr) | 2021-11-05 |
Family
ID=26633032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR09C0037C Active FR09C0037I2 (fr) | 1997-08-28 | 2009-08-14 | Virus de l'encephalite japonaise attenue, adapte a des cellules vero et vaccin contre l'encephalite japonaise |
Country Status (15)
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000083657A (ja) * | 1998-07-13 | 2000-03-28 | Chemo Sero Therapeut Res Inst | 日本脳炎ウイルスワクチン |
| CN1618464A (zh) * | 1998-10-05 | 2005-05-25 | 财团法人阪大微生物病研究会 | 用于抗日本脑炎病毒感染的灭活疫苗的增强免疫原及其生产方法 |
| DK1183332T3 (da) * | 1999-04-22 | 2010-09-06 | Us Agriculture | Porcint Reproduktions- og Respirations Syndrom-vaccine baseret på isolere JA-142 |
| AU4472801A (en) * | 2000-04-07 | 2001-10-23 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Inactivated japanese B encephalitis vaccine and process for producing the same |
| MXPA03011611A (es) * | 2001-06-29 | 2004-07-01 | Becton Dickinson Co | Administracion intradermica de vacunas y agentes terapeuticos genicos a traves de microcanula. |
| JP2007068401A (ja) * | 2003-08-07 | 2007-03-22 | Chemo Sero Therapeut Res Inst | 西ナイルウイルスワクチン |
| DE602005015332D1 (de) * | 2004-02-23 | 2009-08-20 | Crucell Holland Bv | Verfahren zur Reinigung von Viren |
| CN100340596C (zh) * | 2004-05-20 | 2007-10-03 | 佛山市顺德区汉达精密电子科技有限公司 | 回收聚碳酸酯/丙烯腈－丁二烯－苯乙烯共聚物及其回收方法 |
| CA2602944C (en) * | 2005-04-11 | 2015-08-11 | Crucell Holland B.V. | Virus purification using ultrafiltration |
| US8591916B2 (en) * | 2007-01-31 | 2013-11-26 | Sanofi Pasteur Biologics, Llc | Flavivirus vaccine vector against influenza virus |
| KR101623994B1 (ko) * | 2007-12-26 | 2016-05-24 | 기타사토 다이이치 산쿄 백신 가부시키가이샤 | 안정하게 장기간 보존할 수 있는 일본뇌염 백신의 제조방법 및 그 백신의 용도 |
| KR101507822B1 (ko) | 2008-06-04 | 2015-04-24 | 잇빤 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 | 불활성화 일본 뇌염 바이러스 입자를 어쥬번트로서 사용하는 방법 |
| KR101622738B1 (ko) * | 2008-07-30 | 2016-05-19 | 히사미쓰 세이야꾸 가부시키가이샤 | 마이크로니들 디바이스 및 마이크로니들 디바이스에 의한 일본 뇌염 바이러스 항원의 주효성을 상승시키는 방법 |
| WO2010137036A2 (en) * | 2009-05-25 | 2010-12-02 | Panacea Biotec Ltd | Novel japanese encephalitis vaccine and method of manufacturing the same |
| KR101144993B1 (ko) * | 2009-06-18 | 2012-06-27 | 대한민국 | 돼지 일본뇌염 바이러스의 고농축 혈구응집용 항원 |
| ES2647882T3 (es) | 2011-12-06 | 2017-12-27 | Valneva Austria Gmbh | Compuestos de aluminio para su uso en productos terapéuticos y vacunas |
| IN2013CH04135A (enrdf_load_html_response) * | 2013-09-14 | 2015-08-14 | Bharat Biotech Int Ltd | |
| CN105695424B (zh) * | 2015-04-01 | 2019-06-14 | 中国食品药品检定研究院 | 乙型脑炎减毒活疫苗株sa14-14-2在人二倍体细胞2bs上的适应株及其疫苗 |
| WO2017109225A1 (en) * | 2015-12-23 | 2017-06-29 | Valneva Austria Gmbh | Zika virus vaccine |
| CN108697786B (zh) | 2016-01-15 | 2022-05-27 | Km生物医药股份公司 | 含有固定化病毒粒子的疫苗 |
| US11033615B2 (en) | 2016-05-31 | 2021-06-15 | The Government of the United States, As Represented by the Secretary of the Army Fort Detrick, Maryland | Zika virus vaccine and methods of production |
| SG11202001161YA (en) | 2017-09-21 | 2020-03-30 | Valneva Se | Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus chikv-delta5nsp3 |
| MY193736A (en) | 2017-11-03 | 2022-10-27 | Takeda Vaccines Inc | Method for inactivating zika virus and for determining the completeness of inactivation |
| AU2018375789B2 (en) | 2017-11-30 | 2021-11-11 | Takeda Vaccines, Inc. | Method for inactivating Zika virus and related methods |
| CN110684747B (zh) * | 2018-07-06 | 2024-05-24 | 厦门大学 | 灭活及保存呼吸道合胞病毒的方法 |
| WO2020045368A1 (ja) * | 2018-08-27 | 2020-03-05 | マイキャン・テクノロジーズ株式会社 | 不死化単球細胞および誘導細胞を用いた抗感染症薬，ワクチンなどの評価方法 |
| US20230110516A1 (en) | 2020-03-01 | 2023-04-13 | Dynavax Technologies Corporation | Coronavirus vaccines comprising a tlr9 agonist |
| EP3895729A1 (en) | 2020-03-01 | 2021-10-20 | Valneva Austria GmbH | Cpg-adjuvanted sars-cov-2 virus vaccine |
| IL296071A (en) | 2020-03-01 | 2022-11-01 | Valneva Austria Gmbh | Cpg-adjuvanted sars-cov-2 virus vaccine |
| WO2021204825A2 (en) | 2020-04-06 | 2021-10-14 | Valneva Austria Gmbh | INACTIVATED SARS-CoV-2 VIRUS VACCINE |
| WO2023148256A1 (en) | 2022-02-02 | 2023-08-10 | Valneva Austria Gmbh | Inactivated sars-cov-2 virus vaccine |
| EP4428231A1 (en) * | 2022-04-20 | 2024-09-11 | Korea National Institute of Health | High-titer japanese encephalitis virus genotype 5 and use thereof |
| WO2024153686A1 (en) | 2023-01-18 | 2024-07-25 | Valneva Austria Gmbh | Process for virus production in a bioreactor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2704258B2 (ja) * | 1987-10-31 | 1998-01-26 | 日本臓器製薬株式会社 | 組み換えワクチニアウイルス |
| GB8821656D0 (en) * | 1988-09-15 | 1988-10-12 | Health Lab Service Board | Pharmaceutical compositions for eliciting immunostimulant effect |
| JPH085803B2 (ja) * | 1988-11-10 | 1996-01-24 | 武田薬品工業株式会社 | 日本脳炎ワクチンの製造法 |
| EP0562136A1 (en) | 1992-03-24 | 1993-09-29 | Division Of Microbiology, Kyoto Biken Laboratories, Inc. | Live vaccine to getah virus infectious disease, and trivalent live vaccine to Japanese encephalitis virus, porcine parvovirus and getah virus infectious diseases |
| US6010894A (en) * | 1997-06-13 | 2000-01-04 | Research Development Foundation | Method of screening for attenuating viruses |
-
1998
- 1998-08-25 DE DE122009000037C patent/DE122009000037I2/de active Active
- 1998-08-25 JP JP2000508774A patent/JP4161017B2/ja not_active Expired - Lifetime
- 1998-08-25 AU AU90047/98A patent/AU748730B2/en not_active Expired
- 1998-08-25 CA CA002301000A patent/CA2301000C/en not_active Expired - Lifetime
- 1998-08-25 CN CNB988097974A patent/CN1142271C/zh not_active Expired - Lifetime
- 1998-08-25 ES ES05014317T patent/ES2382946T3/es not_active Expired - Lifetime
- 1998-08-25 DE DE69837211T patent/DE69837211T2/de not_active Expired - Lifetime
- 1998-08-25 US US09/486,392 patent/US6309650B1/en not_active Expired - Lifetime
- 1998-08-25 DK DK98941885T patent/DK1025209T3/da active
- 1998-08-25 WO PCT/KR1998/000259 patent/WO1999011762A1/en active IP Right Grant
- 1998-08-25 DK DK05014317.1T patent/DK1604685T3/da active
- 1998-08-25 EP EP05014317A patent/EP1604685B1/en not_active Expired - Lifetime
- 1998-08-25 EP EP98941885A patent/EP1025209B1/en not_active Expired - Lifetime
- 1998-08-25 ES ES98941885T patent/ES2281929T3/es not_active Expired - Lifetime
- 1998-08-25 NZ NZ503522A patent/NZ503522A/en not_active IP Right Cessation
- 1998-08-26 MY MYPI98003899A patent/MY129773A/en unknown
- 1998-08-27 KR KR1019980035007A patent/KR100314404B1/ko not_active Expired - Fee Related
-
2009
- 2009-06-10 NL NL300391C patent/NL300391I2/nl unknown
- 2009-08-14 FR FR09C0037C patent/FR09C0037I2/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR100314404B1 (ko) | 2002-10-12 |
| AU748730B2 (en) | 2002-06-13 |
| EP1604685A3 (en) | 2006-07-05 |
| CA2301000A1 (en) | 1999-03-11 |
| AU9004798A (en) | 1999-03-22 |
| FR09C0037I2 (fr) | 2021-11-05 |
| EP1604685A2 (en) | 2005-12-14 |
| JP4161017B2 (ja) | 2008-10-08 |
| DK1604685T3 (da) | 2012-06-18 |
| US6309650B1 (en) | 2001-10-30 |
| MY129773A (en) | 2007-04-30 |
| DE69837211D1 (de) | 2007-04-12 |
| WO1999011762A1 (en) | 1999-03-11 |
| NL300391I2 (nl) | 2009-11-02 |
| EP1025209A1 (en) | 2000-08-09 |
| JP2001514844A (ja) | 2001-09-18 |
| DE122009000037I2 (de) | 2011-06-16 |
| NZ503522A (en) | 2001-06-29 |
| KR19990023955A (ko) | 1999-03-25 |
| ES2382946T3 (es) | 2012-06-14 |
| DK1025209T3 (da) | 2007-06-25 |
| EP1025209B1 (en) | 2007-02-28 |
| CA2301000C (en) | 2003-07-08 |
| DE69837211T2 (de) | 2007-12-06 |
| EP1604685B1 (en) | 2012-02-22 |
| DE122009000037I1 (de) | 2009-11-05 |
| ES2281929T3 (es) | 2007-10-01 |
| CN1142271C (zh) | 2004-03-17 |
| CN1272879A (zh) | 2000-11-08 |
| NL300391I1 (nl) | 2009-08-03 |